Login / Signup

Intranasal administration of a virus like particles-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern.

Dominik A RothenPascal S KrengerAleksandra NonicIna BalkeAnne-Cathrine S VogtXinyue ChangAlessandro ManentiFabio VedoviGunta ResevicaSenta M WaltonAndris ZeltinsEmanuele MontomoliMonique VogelMartin F BachmannMona O Mohsen
Published in: Allergy (2022)
-RBD induces a protective systemic and local specific antibody response against SARS-CoV-2 and its VOCs.
Keyphrases
  • sars cov
  • respiratory syndrome coronavirus
  • copy number
  • dengue virus
  • gene expression
  • dna methylation
  • zika virus